Scrip100: Life as a One Hit Wonder
This article was originally published in Scrip
The road to pop stardom is littered with chart-topping singers who only ever hit the big time once, leaving everyone wondering "where are they now?" Similarly, the pharma industry has a number of players whose success relies heavily on just one drug. Scrip has used our annual number crunch, the Scrip100, to pick out six "One Hit Wonder" companies – firms with very specific yet successful products on the market – and considered the different paths they have followed after their time in the limelight.
You may also be interested in...
Angeli Möller, recently spotlighted by In Vivo as a 2020 Rising Leader, has quickly moved up the ranks at Bayer and is now spearheading one of its key initiatives to bring artificial intelligence and machine learning technologies into the pharma business.
Coaching and mentoring are important tools for the leaders of today to be able to foster the next generation of talent in the biopharma sector. While the routes into industry have not changed dramatically – most leaders hold a master’s degree and/or PhD – the expectations of rising leaders have altered and the industry itself has become more collaborative.
In this first edition of In Vivo's ‘Rising Leaders’ list, the focus is on entrepreneurs and innovators who represent the next wave of creativity in health care.